These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34681806)

  • 21. Innate Effector Systems in Primary Human Macrophages Sensitize Multidrug-Resistant Klebsiella pneumoniae to Antibiotics.
    Rekha RS; Karadottir H; Ahmed S; Gudmundsson GH; Agerberth B; Bergman P
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32513857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures.
    Wu GQ; Ding JX; Li LX; Wang HL; Zhao R; Shen ZL
    Curr Microbiol; 2009 Aug; 59(2):147-53. PubMed ID: 19459007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors.
    Llobet E; Campos MA; Giménez P; Moranta D; Bengoechea JA
    Infect Immun; 2011 Sep; 79(9):3718-32. PubMed ID: 21708987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical Bactericidal Effects of Hydrophobic Lung Surfactant Proteins and Their Peptide Mimics Using Liposome Molecular Trojan.
    Dutta K; Nag K; Booth V; Smyth E; Dueck H; Fritzen-Garcia M; Ghosh C; Panda AK
    J Oleo Sci; 2018 Aug; 67(8):1043-1057. PubMed ID: 30012899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New concepts in collectin-mediated host defense at the air-liquid interface of the lung.
    McCormack FX
    Respirology; 2006 Jan; 11 Suppl():S7-10. PubMed ID: 16423276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Long Pentraxin PTX3 Controls
    Asgari F; Supino D; Parente R; Polentarutti N; Stravalaci M; Porte R; Pasqualini F; Barbagallo M; Perucchini C; Recordati C; Magrini E; Mariancini A; Riva F; Giordano A; Davoudian S; Roger T; Veer CV; Jaillon S; Mantovani A; Doni A; Garlanda C
    Front Immunol; 2021; 12():666198. PubMed ID: 34093560
    [No Abstract]   [Full Text] [Related]  

  • 29. Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model.
    Bartlett KH; McCray PB; Thorne PS
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3901-6. PubMed ID: 14638500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich O-antigens.
    Sahly H; Ofek I; Podschun R; Brade H; He Y; Ullmann U; Crouch E
    J Immunol; 2002 Sep; 169(6):3267-74. PubMed ID: 12218146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of
    Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
    Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
    Elemam A; Rahimian J; Doymaz M
    J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A
    Kidd TJ; Mills G; Sá-Pessoa J; Dumigan A; Frank CG; Insua JL; Ingram R; Hobley L; Bengoechea JA
    EMBO Mol Med; 2017 Apr; 9(4):430-447. PubMed ID: 28202493
    [No Abstract]   [Full Text] [Related]  

  • 34. Prekallikrein - an emerging therapeutic target for Klebsiella pneumoniae infection?
    Lam Z; Condliffe AM
    J Pathol; 2020 Apr; 250(4):359-361. PubMed ID: 31943204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-Specific Regulation of Gene Expression Networks by Surfactant Protein A (SP-A) Variants in Alveolar Macrophages in Response to
    Thorenoor N; Kawasawa YI; Gandhi CK; Floros J
    Front Immunol; 2020; 11():1290. PubMed ID: 32670284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
    J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.
    Wu G; Wu P; Xue X; Yan X; Liu S; Zhang C; Shen Z; Xi T
    Peptides; 2013 Jul; 45():73-7. PubMed ID: 23643614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of Surfactant Protein-A1 and SP-A2 Transgenic Mice After
    Thorenoor N; Umstead TM; Zhang X; Phelps DS; Floros J
    Front Immunol; 2018; 9():2404. PubMed ID: 30459763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
    Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
    Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    Arzneimittelforschung; 2005; 55(8):473-7. PubMed ID: 16149716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.